FKRP and cardiomyopathy: Systemic delivery to FKRPL276I mice at multiple ages rendered body-wide FKRP protein expression and restored glycosylation of α-DG in both skeletal and cardiac muscles, thereby ameliorating the dystrophic pathology and cardiomyopathy.